Resonance Health (RHT) is an Australian healthcare company specialising in the development and commercialisation of magnetic resonance imaging (MRI) related technology for the diagnosis and management of human disease.
The services provided by Resonance Health have gained endorsement by leading physicians worldwide for their reliability in providing quantitative information essential in the management of particular diseases.
Resonance Health’s dedication to scientific rigour in the development and implementation of its analysis services has enabled it to achieve regulatory clearances in the US, Europe and Australasia. This extends to a philosophy of quality management in all aspects of its operations. Resonance Health proudly carries ISO 9001 and ISO 13485 accreditation.
 
FerriScan provides quality assured data acquisition and analysis accredited to international quality standards ISO 9001 and ISO 13485
|
Resonance Health’s lead product is FerriScan, a world leading non-invasive tool for measuring liver iron concentration; the first such test to have achieved international regulatory approvals.
Resonance Health has representation in Australia, UK, Germany and the USA and a distributor in Turkey. This enables FerriScan to achieve and maintain a significant profile amongst physicians and patient groups in its relevant clinical communities.
|
Resonance Health has also launched a FerriScan and cardiac T2* dual analysis service, providing further information to inform clinical decisions on disease management. Further products are currently in development undergoing validation and testing to maintain the highest levels of clinician confidence.
|
Login
